Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status
Raksha Shrestha, Shigeru Chiba(University of Tsukuba), Manabu Kusakabe(BC Cancer Agency), Mamiko Sakata‐Yanagimoto(University of Tsukuba Hospital), Toshiya Inaba(Hiroshima University), Atsushi Iwama(Chiba University), Yuichi Shiraishi(The University of Tokyo), Ryunosuke Saiki(Kyoto University), Seishi Ogawa(Keio University), Kenichi Chiba(The University of Tokyo), Hideki Makishima(Kyoto University), Olivier Bernard(Université de Poitiers), Tatsuhiro Sakamoto(University of Tsukuba), Yaeko Nakajima‐Takagi(Chiba University), Hirotaka Matsui(Hiroshima University), Yasuhito Suehara, Yasuhito Nannya(Kyoto University), Enguerran Mouly(Inserm), Hideharu Muto(University of Tsukuba), Haruhiko Koseki(RIKEN Center for Integrative Medical Sciences), Satoru Miyano(Cardiovascular Institute Hospital), Kota Fukumoto, Koichiro Maie, Motohiko Oshima(The University of Tokyo), Hiroo Ueno(Kyoto University), Takayasu Kato(University of Tsukuba), Masatomo Ishihara
Cited by 19
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
|PLoS Genetics|2008|1k
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
|Journal of Clinical Oncology|2013|543